Erbulozole
Tools
Actions
General
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
Chemical compound
Clinical data | |
---|---|
Other names | Erbuzole |
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C24H27N3O5S |
Molar mass | 469.56 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Erbulozole (R55104) is a congener of the microtubule inhibitor tubulozole. It is undergoing phase I clinical trials as a chemotherapeutic agent.[1]
Synthesis
[edit]References
[edit]Other reading
[edit]- Distelmans W, VanGinckel P, Heeres J, Van der Veken LJ (1991). "Erbulozole. Antineoplastic, Microtubule inhibitor". Drugs Future. 16 (6): 577.
CI monoclonal antibodies ("-mab") |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Tyrosine kinase inhibitors ("-nib") |
| ||||||||
Other |
|
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |